<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Normobaric <z:mp ids='MP_0002319'>hyperoxia</z:mp> treatment has recently been demonstrated to be remarkably beneficial in <z:hpo ids='HP_0011009'>acute</z:hpo> focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The present study compared <z:mp ids='MP_0002319'>hyperoxia</z:mp> treatment with a novel heliox treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Adult male rats breathed 30% oxygen and 70% nitrogen (control group), 100% oxygen (<z:mp ids='MP_0002319'>hyperoxia</z:mp> group), or 30% oxygen and 70% <z:chebi fb="64" ids="30217">helium</z:chebi> (heliox group) during a middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 2 h and a 1-hour reperfusion (n=6 in each group) </plain></SENT>
<SENT sid="3" pm="."><plain>Neurological deficits were scored at 3 and 24 h post focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Neither the physiological parameters (body temperature, blood pressure, heart rate, <z:chebi fb="0" ids="15379">O(2)</z:chebi> saturation, and laser Doppler cerebral blood) nor the 3-hour post <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> neurological scores differed between groups </plain></SENT>
<SENT sid="5" pm="."><plain>However, the neurological scores showed a statistically significant improvement at 24 h post <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the heliox group (p&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (mean+SD) as measured by 2,3,5-triphenyltetrazolium staining included 36+/-17% of the involved hemisphere in the control group, 16+/-14% in the <z:mp ids='MP_0002319'>hyperoxia</z:mp> group, and 4+/-2% in the heliox group (p&lt;0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, whereas <z:mp ids='MP_0002319'>hyperoxia</z:mp> reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, heliox further reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and improved 24-hour neurological deficits in a rat model of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>This suggests that a greater benefit may accrue from heliox therapy </plain></SENT>
</text></document>